参考文献/References:
[1] Sarkar S, Mazumder U, Rahman K, et al. Fibrous dysplasia
on theskull [J]. Mymensingh Med J, 2008, 17(1): 55-59.
[2] Valentini V, Cassoni A, Terenzi V, et al. Our experience in
the surgical management of craniofacial fibrous dysplasia:
what has changed in the last 10 years [J]? Acta Otorhino-
laryngol Ital, 2017, 37(5): 436-443.
[3] Menon S, Venkatswamy S, Ramu V, et al. Craniofacial dys-
plasia: surgery and literature review [J]. Ann Maxillofac
Surg, 2013, 3(1): 66-71.
[4] Sirvanci M, Karaman K, Onat L, et al. Monostotic fibrous
dysplasia of the clivus: MRI and CT findings [J]. Neuro-
radiology, 2002, 44(9): 847-850.
[5] Okamotos S, Hisaoka M, Meis JM, et al. Juxta-articular
myxoma and. intramuscular myxoma are two distinct
entities activating Gsα mutation at Arg 201 codon does not
occur in juxta articular myxoma [J]. Virchows Arch, 2002,
440(1): 12-15.
[6] Candeliere GA, Roughley PJ, Glorieux FH, et al. Polymerase
chain reaction-based technique for the selective enrich-
ment and analysis of mosaic arg201 mutations in G alpha s
from patients with fibrous dysplasia of bone [J]. Bone, 1997,
21(2): 201-206.
[7] Pollandt K, Engels C, Kaiser E, et al. Gsα gene mutations in
monostotic fibrous dysplasia of bone and fibrous dysplasia-
like low-grade central osteosarcoma [J]. Virchows Arch,
2001, 439(2): 170-175.
[8] 药立波. 医学分子生物学[M]. 北京：人民卫生出版社，
2004. 104-105.
[9] Chanson P, Salenave S, Orcel P, et al. McCune-Albright
syndrome in adulthood [J]. Pediatr Endocrinol Rev, 2007, 4
(4): 453-462.
[10] Weinstein LS, Shenker A, Gejman PV, et al. Activating
mutations of the stimulatory G protein in the McCune-
Albright syndrome [J]. N Engl J Med, 1991, 325(24): 1688-
1695.
[11] Bianco P, Kuznetsov SA, Riminucci M, et al. Reproduction
of human fibrous dysplasia of bone in immunocompromised
mice by transplanted mosaics of normal and Gsalpha-
mutated skeletal progenitor cells [J]. Clin Invest, 1998, 101
(8): 1737-1744.
[12] Dal Cin P, Sciot R, Brys P, et al. Recurrent chromosome
aberrations in fibrous dysplasia of the bone: a report of the
CHAMP study group: chromosomes and morphology [J].
Cancer Genet Cytogenet, 2000, 122(1): 30-32.
[13] Riminucci M, Kuznetsov SA, Cherman N, et al. Osteoclasto-
genesis in fibrous dysplasia of bone: in situ and in vitro
analysis of IL-6 expression [J]. Bone, 2003, 33(3): 434-442.
[14] Riminucci M, Saggío I, Robey GP, et al. Fibrous dysplasia
as a stem cell disease [J]. J Bone Miner Res, 2006, 21
Suppl 2: 125-131.
[15] Kumta SM, Huang L,Cheng YY, et al. Expression of VEGF
and MMP-9 in giant cell tumor of bone and other osteolytic
lesions [J]. Life Sci, 2003, 73(11): 1427-1436.
[16] Yasuoka T, Takagi N. Fibrous dysplasia in the maxilla:
possible mechanism of bone remodeling by calcitonin
treatment [J]. Oral Oncol, 2003, 39(39): 301-305.
[17] 赵继宗. 颅脑肿瘤外科学[M]. 北京：人民卫生出版社，
2003. 625-626.
[18] 王忠诚. 神经外科学[M]. 武汉：湖北科学技术出版社，
2008. 897.
[19] 方 燕，刘鹏程，高文清，等. 颅面骨骨纤维结构不良与骨
化性纤维瘤的CT鉴别[J]. 中国临床医学影像杂志，
2003，14（2）：119-121.
[20] Hanifi B, Samil KS, Yasar C, et al. Craniofacial fibrous dys-
plasia [J]. Clin Imaging, 2013, 37(6): 1109-1115.
[21] Chapurlat RD, Delmas PD, Liens D, et al. Long term effects
of intravenous pamidronate in fibrous dysplasia of bone [J].
J Bone Miner Res, 1997, 12(2): 1746-1752.
[22] Lala R, Matarazzo P, Bertelloni S, et al. Pamidronste treat-
ment of bone fibrous dysplasia in nice children with
McCune-Albright syndrome [J]. Acta Paediatr, 2000, 89(2):
188-193.
[23] 傅继弟，赵景武，殷大力，等. 神经导航技术外科治疗颅骨
纤维异常增生[J]. 中华医学杂志，2004，84（10）：808-812.
[24] Sammut SJ, Kandasamy J, Newman W, et al. Relief of
severe retroorbital pain and vision improvement after optic
nerve decompression in polyostotic fibrous dysplasia: case
report and review of the literature [J]. Childs Nerv Syst,
2008, 24(4): 515-520.
[25] Tan YC, Yu CC, Chang CN, et al. Optic nerve compression
in craniofacial fibrous dysplasia: the role and indications
for decompression [J]. Plast Reconstr Surg, 2007, 120(7):
1957-1962.
[26] 张 鑫，胡晓蓉，李卫国，等. 颅骨纤维结构不良42例临
床分析 [J]. 山东大学学报，2015，53（10）：91-96.
[27] 申璐敏，胡莹莹，李 鑫，等. 颅骨多发骨纤维异常增生症
1例报告及文献复习[M]. 中国口腔颌面外科杂志，2016，
14（4）：381-384
[28] Bianco P, Riminucci M, Majolagbe A, et al. Mutations of the
GNAS1 gene, stromal cell dysfunction, and osteomalacic
changes in non-McCune-Albright fibrous dysplasia of bone
[J]. J Bone Miner Res, 2000, 15(1): 120-128.
相似文献/References:
[1]杜彦挺 综述 潘亚文 审校.Moyamoya病的诊断和治疗的研究进展[J].中国临床神经外科杂志,2015,(12):761.[doi:10.13798/j.issn.1009-153X.2015.12.021]
[2]陈 娟 张华楸 综述 雷 霆 审校.库欣病发病机制的研究进展[J].中国临床神经外科杂志,2015,(10):594.[doi:10.13798/j.issn.1009-153X.2015.10.006]
[3]王米君 综述 舒 凯 审校.脑膜瘤瘤周水肿的研究现状[J].中国临床神经外科杂志,2015,(05):315.[doi:10.13798/j.issn.1009-153X.2015.05.022]
[4]管得宁,张 扬,徐 运.帕金森病的发病机制及治疗研究进展[J].中国临床神经外科杂志,2016,(11):732.[doi:10.13798/j.issn.1009-153X.2016.11.031]
[5]陆丽娟,李玉凤,赵喜庆 综述,等.氯离子通道与胶质瘤的关系研究进展[J].中国临床神经外科杂志,2016,(12):803.[doi:10.13798/j.issn.1009-153X.2016.12.029]
[6]吴 超 于 涛 王振宇 段丽萍.脊髓损伤后神经源性肠功能障碍的发生机制[J].中国临床神经外科杂志,2017,(04):282.[doi:10.13798/j.issn.1009-153X.2017.04.030]
[7]吕艳霞 李安荣 杨朋磊 综述 胡钧涛 审校.炎症反应在颅内动脉瘤发生中作用的研究进展[J].中国临床神经外科杂志,2017,(05):363.[doi:10.13798/j.issn.1009-153X.2017.05.030]
[8]马 涛.颅脑损伤后凝血功能障碍的机制及干预措施[J].中国临床神经外科杂志,2017,(08):601.[doi:10.13798/j.issn.1009-153X.2017.08.030]
[9]田 杨 综述,史怀璋 审校.非编码RNA参与颅内动脉瘤病理机制的研究进展[J].中国临床神经外科杂志,2018,(10):701.[doi:10.13798/j.issn.1009-153X.2018.10.021]
[10]曾子桓 张 灏 陈伟强 魏梁锋 王守森.颅脑损伤后继发性脑损伤发病机制的研究进展[J].中国临床神经外科杂志,2019,(12):777.[doi:10.13798/j.issn.1009-153X.2019.12.022]